title: Improvements in Depression and Changes in Fatigue: Results from the SLAM DUNC Depression Treatment Trial.
abstract: Fatigue and depression are common co-morbid conditions among people with HIV infection. We analyzed a population of HIV-infected adults with depression, who were enrolled in a depression treatment trial, to examine the extent to which improvements in depression over time were associated with improvements in HIV-related fatigue. Data for this analysis come from a randomized controlled trial to evaluate the effectiveness of improved depression treatment on antiretroviral adherence. Fatigue was measured using the HIV-Related Fatigue Scale, and depressive symptoms were measured with the Hamilton Depression Rating Scale. Participants (n = 234) were on average nearly 44 years of age and predominantly male, black or African American, and unemployed. Individuals who experienced stronger depression response (i.e., greater improvement in depression score) had larger decreases in fatigue. However, even among those who demonstrated a full depression response, nearly three-quarters continued to have either moderate or severe fatigue at 6 and 12 months.
authors.affiliation: College of Nursing, Medical University of South Carolina, Charleston, SC, USA. julievbarroso@gmail.com.
authors.forename: Julie
authors.initials: J
authors.lastname: Barroso
authors.affiliation: Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, USA.
authors.forename: Angela M
authors.initials: AM
authors.lastname: Bengtson
authors.affiliation: Department of Psychiatry, University of North Carolina-Chapel Hill, Chapel Hill, USA.
authors.forename: Bradley N
authors.initials: BN
authors.lastname: Gaynes
authors.affiliation: School of Nursing, University of Alabama-Birmingham, Birmingham, USA.
authors.forename: Teena
authors.initials: T
authors.lastname: McGuinness
authors.affiliation: Division of Infectious Diseases, University of North Carolina-Chapel Hill, Chapel Hill, USA.
authors.forename: Evelyn B
authors.initials: EB
authors.lastname: Quinlivan
authors.affiliation: Warren-Vance Community Health Center, Henderson, NC, USA.
authors.forename: Michelle
authors.initials: M
authors.lastname: Ogle
authors.affiliation: Division of Infectious Diseases, University of North Carolina-Chapel Hill, Chapel Hill, USA.
authors.forename: Amy
authors.initials: A
authors.lastname: Heine
authors.affiliation: Division of Infectious Diseases, Duke University, Durham, USA.
authors.forename: Nathan M
authors.initials: NM
authors.lastname: Thielman
authors.affiliation: Department of Epidemiology, University of North Carolina-Chapel Hill, Chapel Hill, USA.
authors.forename: Brian W
authors.initials: BW
authors.lastname: Pence
mesh_terms: D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003863:Depression / Q000188:drug therapy / Q000453:epidemiology; D003865:Major Depressive Disorder / Q000188:drug therapy* / Q000453:epidemiology; D004305:Dose-Response Relationship, Drug; D005221:Fatigue / Q000453:epidemiology / Q000523:psychology; D005260:Female; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy / Q000523:psychology*; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D015999:Multivariate Analysis; D009483:Neuropsychological Tests; D011569:Psychiatric Status Rating Scales; D011788:Quality of Life; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D012959:Socioeconomic Factors; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D044966:Anti-Retroviral Agents; D000928:Antidepressive Agents
keywords: Depression; Fatigue; Intervention; Syndemic